CoChat

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Oral isotretinoin for acne: a complete overview

Villani, Alessia, Nastro, Francesca, Di Vico, Francesca, Fabbrocini, Gabriella, Annunziata, Maria Carmela, Genco, Lucia · 2022 · Expert Opinion on Drug Safety

Abstract

INTRODUCTION: Acne is one of the most common and widespread skin conditions, affecting the health as much as patients' quality of life. A wide variety of treatments for acne, topical and systemics, could be prescribed, depending on its degree of severity. Isotretinoin, a derivative of retinol, has been widely used for the treatment of severe forms of acne and those forms not responding to conventional treatments. In literature, there are several studies describing its efficacy, also reporting side-effects related to the drug; therefore, this has led the scientific community to request further studies qualifying its characteristics and comparing its efficacy and safety with other classic acne treatments, as well as with different treatment regimes, in order to find the dose with the best efficacy/safety ratio. AREAS COVERED: The aim of this article is to provide a complete overview on the use of oral isotretinoin for the treatment of acne describing the efficacy, safety, and tolerability of the drug. EXPERT OPINION: Oral isotretinoin represents a valid therapeutic alternative in treating severe and mild-to-moderate acne lesions, also reducing scarring damage. There are no standardized protocols regarding the use of oral isotretinoin and its association with other therapies; however, the correct patient selection and a tailored treatment protocol according to acne lesions severity and type should be considered in order to obtain optimal results.

Overview

Integrity signals

Registry

Crossref · 10.1080/14740338.2022.2102605

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 98 references

Research works printed but not linked: 12

  1. Al Muqarrab F, 2022, Dermatol Ther, 9, e15311
  2. Webster GF, 2014, J Drugs Dermatol, 13, 665
  3. Del Rosso JQ, 2019, J Clin Aesthet Dermatol, 12, 13
  4. Zaenglein AL, 2020, J Clin Aesthet Dermatol, 13, 15
  5. Pandey D, 2019, Kathmandu Univ Med J (KUMJ), 17, 14
  6. Hasibur MR, 2013, Mymensingh Med J, 22, 42
  7. Wahab MA, 2008, J Pak Assoc Derma, 18, 9
  8. Gollnick HP, 2001, Eur J Dermatol, 11, 538
  9. Del Rosso JQ, 2013, J Drugs Dermatol, 12, 626
  10. Magin P, 2005, Br J Gen Pract, 55, 134
  11. Hughes RA, 1993, J Rheumatol, 20, 1241
  12. Krishna S, 2012, J Am Acad Dermatol, 66, AB19

Cited by

See all 42

Metadata

Authors
Villani, A., Nastro, F., Di Vico, F., Fabbrocini, G., Annunziata, M. C., & Genco, L.
Affiliations
  • University of Naples Federico II (IT)
  • Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Corresponding author
Villani, Alessia
Venue
Expert Opinion on Drug Safety
Published
2022-07-21
Volume
21
Issue
8
Pages
1027-1037
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W4285793277
Cited by
42
References
98
Citations by year
2026: 12 · 2025: 10 · 2024: 11 · 2023: 7 · 2022: 2
FWCI
1.33
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
Keywords
isotretinoin, oral isotretinoin, acne, severe acne, retinoids, treatment efficacy, drug safety, tolerability, acne scars, patient selection, treatment protocols, dose optimization
MeSH terms
Acne Vulgaris, Administration, Oral, Dermatologic Agents, Humans, Quality of Life, Isotretinoin, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral isotretinoin for acne: a complete overview. https://app.cochat.ai/papers/10.1080/14740338.2022.2102605
The paper
Villani, A., Nastro, F., Di Vico, F., Fabbrocini, G., Annunziata, M. C., & Genco, L. (2022). Oral isotretinoin for acne: a complete overview. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2022.2102605

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.